期刊文献+

恶性肿瘤风险指数在卵巢恶性肿瘤术前诊断中的价值 被引量:1

Value of malignancy risk index in pre-operative diagnosis of ovarian malignant tumors
下载PDF
导出
摘要 回顾性总结165例卵巢肿瘤患者临床资料,分别以绝经状态、超声评分、血清CA125及恶性肿瘤风险指数对卵巢肿瘤的良、恶性进行预测,结果表明绝经后状态的敏感性为68%,特异性为64%,阳性预测值为53%;超声评分≥2的上述指标分别为77%、84%、70%;血清CA125>35 U/ml的上述指标分别为76%、86%、73%;恶性肿瘤风险指数(RMI)>200的上述指标分别为72%、92%、83%。这提示RMI较其他指标对卵巢肿瘤良、恶性的预测更为准确,具有较大的临床应用价值。 Totally 165 women received surgical excision of ovarian masses were studied. The sensitivity,specificity ,and positive predictive value of serum CA125,ultrasound score,menopausal status,and risk of malignancy index(RMI) were used to diagnoze ovarian malignant tumor. It was found that the sensitivity .specificity and positive predictive value of menopausal status were 68%,64% and 53% respectively;those of ultrasound socre>2 were 77%,84% and 70%;of CA125>35 U/ml were 76%,86% and 73%;and of RM1>200 were 72%,92% and 93%. Results showed that the RMI was more accurate than menopausal status, ultrasound score, and CA125 in diagnosing cancer. It can be introduced easily into clinical practice.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2003年第10期1159-1160,共2页 Academic Journal of Second Military Medical University
关键词 卵巢肿瘤 恶性肿瘤风险指数 诊断 临床应用 ovarian neoplasms risk of malignancy index diagnosis
  • 相关文献

参考文献7

  • 1马水清,沈铿,郎景和.恶性肿瘤风险指数在卵巢恶性肿瘤术前诊断中的作用[J].中华妇产科杂志,2001,36(3):162-164. 被引量:33
  • 2Gillis CR,Hole DJ,Still RM,et al. Medical audit,cancer registration, and survival in ovarian cancer[J]. Lancet, 1991,337(8741):611-612.
  • 3Morgante G, la-Marca A, Ditto A,et al. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses[J], Br J Obstet Gynaecol, 1999,106 (6):524-527.
  • 4Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses[J]. Br J Obstet Gynaecol, 1996,103 (8) : 826-831.
  • 5Inoue M, Fujita M, Nakazawa A, et al. Sialyl-Tn, Sialyl-Lewis Xi, CA19-9, CA125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors[J]. Obstet Gynaecol, 1992,79 (3): 434-436.
  • 6Jacobs I,Oram D,Fairbanks J,et al. A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer[J]. Br J Obstet Gynaecol,1990,97(10):922-929.
  • 7Davies AP,Jacobs I, Woolas R ,et al. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index[J]. Br J Obstet Gynaecol, 1993,100(10) : 927-931.

二级参考文献3

  • 1Giuseppe M,Br J Obstet Gynaecol,1999年,106卷,524页
  • 2Tingulstad S,Br J Obstet Gynaecol,1996年,103卷,826页
  • 3Gillis C R,Lancet,1991年,337卷,611页

共引文献32

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部